Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Oriental Fortune Capital

Founders Wei Chen

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 250
Average round size
info
The average size of a deal this fund participated in
$18M
Portfolio companies 216
Rounds per year 14.71
Lead investments 43
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits 23
Key employees 6
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Software
  • Information Technology
  • E-Commerce
  • Manufacturing
  • Artificial Intelligence
Summary

The main office of represented VC is situated in the Shenzhen. The fund was located in Asia if to be more exact in China.

The higher amount of exits for fund were in 2019. The high activity for fund was in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Oriental Fortune Capital the average startup value is 100-500 millions dollars. This Oriental Fortune Capital works on 26 percentage points less the average amount of lead investments comparing to the other organizations. The fund is constantly included in 7-12 investment rounds annually. Speaking about the real fund results, this VC is 21 percentage points more often commits exit comparing to other organizations.

Besides them, we counted 12 critical employees of this fund in our database.

The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Jiuxian, Dada, Tuya. Among the most successful fund investment fields, there are Enterprise Software, Marketing. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Oriental Fortune Capital, startups are often financed by ZhenFund, China Growth Capital, Sequoia Capital China. The meaningful sponsors for the fund in investment in the same round are Shenzhen Guozhong Venture Capital Management, Shenzhen Capital Group, Sequoia Capital China. In the next rounds fund is usually obtained by Tencent Holdings, ZhenFund, TAL Education Group.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Oriental Fortune Capital:
Typical Co-investors
Oriental Fortune Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Oriental Fortune Capital:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Renshuo Solar

Energy
Manufacturing
Solar
18 Jan 2024 Suzhou, Jiangsu, China

LongBio Pharma

Biotechnology
Medical
Pharmaceutical
$15M31 Oct 2023 Pudong, Shandong, China

Tianfu Energy Storage

Battery
Energy
Manufacturing
30 Oct 2023 Chengdu, Sichuan, China

Lecheng Smart

Electronics
Laser
Manufacturing
09 Sep 2023 Suzhou, Jiangsu, China

Pinfeng Medical

Health Diagnostics
Manufacturing
Medical
21 Aug 2023 Minhang, Shanghai, China

Microtreat

18 Jul 2023 Suzhou, Jiangsu, China

Gene Cradle

Genetics
Medical
$15M16 Jun 2023 Beijing, Beijing, China

Hengliu Technology

Chemical
Manufacturing
01 Jun 2023 Suzhou, Jiangsu, China

Tonglu Technology

Health Care
Health Diagnostics
Medical
08 May 2023 Shenzhen, Guangdong, China
News
Raythink Raises Tens of Millions of Yuan Series A Funding

– Raythink, a Shenzhen, China-based in-vehicle AR display technology company, raised an undisclosed amount in Series A funding.
– The round – of tens of millions of yuan – was led by Plum Ventures with participation Qianhai FOF, Weed Ventures, Oriental Fortune Capital.
– The company intends to use the funds for a rail transit laboratory, HUD (heads-up display) mass production and automotive-grade certification.

Teon Therapeutics Completes $30 Million Series A Financing

– Teon Therapeutics completed a $30m Series A financing.
– The financing was led by Oceanpine Capital with participation from additional new investors Oriza Ventures, Lifespan Investments, and former Gilead senior executives.
– All existing investors also participated in the financing round including Northern Light Venture Capital, Kaitai Capital and Oriental Fortune Capital.
– The funds will be used to advance the company’s lead A2BR-selective antagonist TT-702 into the clinic as well as to build the company’s pipeline.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Oriental Fortune Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 250
Average round size 18M
Rounds per year 14.71
Peak activity year 2016
Lead investments 43
Follow on index 0.14
Exits 23
Group Appearance index 0.74

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Renshuo Solar

Energy
Manufacturing
Solar
18 Jan 2024 Suzhou, Jiangsu, China

LongBio Pharma

Biotechnology
Medical
Pharmaceutical
$15M31 Oct 2023 Pudong, Shandong, China

Tianfu Energy Storage

Battery
Energy
Manufacturing
30 Oct 2023 Chengdu, Sichuan, China

Lecheng Smart

Electronics
Laser
Manufacturing
09 Sep 2023 Suzhou, Jiangsu, China

Pinfeng Medical

Health Diagnostics
Manufacturing
Medical
21 Aug 2023 Minhang, Shanghai, China

Microtreat

18 Jul 2023 Suzhou, Jiangsu, China

Gene Cradle

Genetics
Medical
$15M16 Jun 2023 Beijing, Beijing, China

Hengliu Technology

Chemical
Manufacturing
01 Jun 2023 Suzhou, Jiangsu, China

Tonglu Technology

Health Care
Health Diagnostics
Medical
08 May 2023 Shenzhen, Guangdong, China
Crunchbase icon

Content report

The following text will be sent to our editors: